331.5: Induction therapy in kidney transplantation using kidney from expanded criteria donor: long term results comparing anti-IL2 receptor antibody and anti-thymocyte globulin.

Background: The use rabbit anti-thymocyte globulin (rATG) seems to offer potential benefits associated with ischemic reperfusion injury (IRI). The aim of this study was to compare the long term efficacy and safety of rATG and anti-IL2 receptor antibody (basiliximab) in patients who got kidney transplants from expanded criteria donors (ECD) who are known to be more vulnerable to IRI. Methods: 128 patients who got kidney transplants from ECDs...